Search results for: Health Policy and Regulation
Filter search results
Don’t Look Back? Voluntary and Charitable Finance of Hospitals
1 July 2001
…the state and funded initially by charitable gifts, these hospitals cared for the acute sick before 1948 and were the centres of research and teaching. We discuss their performance, and…
OHE at the 2019 Health Technology Assessment International (HTAi) Annual Meeting
7 June 2019
…of value; flexible, value-based, indication-specific pricing of complementary diagnostic tests and medicines; ongoing real-world evidence generation; and appropriate methods to divide and reward value among complementary diagnostic tests and medicines….
Can Conventional Blood Tests Predict Future Disability Risks?
25 September 2019
…least – for wider use of objective measures of health (including blood-based biomarkers) by social scientists, health economists, and policymakers. Davillas, A., & Pudney, S., 2019. Biomarkers as precursors of…
Science in Medicine: How Far Has It Advanced?
1 January 1993
The chapters in this book are based on contributions to a seminar organised jointly by the Office of Health Economics and the International Science Policy Foundation, and held at the…
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
…health gain, and expert opinion to estimate cost savings and AMR specific elements of diversity; transmission; enablement; spectrum benefits; and the insurance benefits of the new antibiotic. Contracting: which is…
Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
1 April 2017
…Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special… The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th…
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…both public and private health systems. Societal preference research can help achieve this. For example, a recent OHE study explored views in England and Wales on prioritising new medical treatments….
Neil McAuslane
9 April 2025
…new medicines, building quality into the review process, decision making and HTA and regulatory alignment. He has edited and co-authored several publications and reports covering both regulatory and HTA topics….
OHE at HESG Winter 2021
11 January 2021
…and chaired lively and thought-provoking discussions on various topics as outlined below: On Wednesday 6th January, Chris Sampson lead a discussion on ‘The FLIGHT trial. Whose decision matters and what…